팝업레이어 알림

Breaking
New Ground

in Cancer Immunotherapy

Together,

We face the challenges of cancers for your loved ones

SCROLL DOWN

ABOUT US

is

A next-gen biotech company that can present a new paradigm
in immunotherapy for cancers, and its world-class experts have established
a platform technology to introduce a new target, ONCOKINE™,
that induces cancer cells to become refractory to the current treatment.

READ MORE
Our Science

PIPELINES

ONCOKINE™ is a group of validated targets discovered by NEX-I's proprietary platform.

READ MORE